Tower Research Capital LLC TRC Sells 9,650 Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA)

Tower Research Capital LLC TRC trimmed its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 59.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,570 shares of the pharmacy operator’s stock after selling 9,650 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Walgreens Boots Alliance were worth $359,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Nelson Roberts Investment Advisors LLC bought a new stake in shares of Walgreens Boots Alliance in the first quarter valued at about $25,000. Meridian Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance in the first quarter valued at about $25,000. Weaver Consulting Group bought a new stake in shares of Walgreens Boots Alliance in the first quarter valued at about $27,000. Sageworth Trust Co bought a new stake in shares of Walgreens Boots Alliance in the second quarter valued at about $27,000. Finally, First Interstate Bank raised its holdings in shares of Walgreens Boots Alliance by 228.1% in the second quarter. First Interstate Bank now owns 607 shares of the pharmacy operator’s stock valued at $33,000 after acquiring an additional 422 shares in the last quarter. Institutional investors and hedge funds own 59.70% of the company’s stock.

Shares of WBA stock traded up $1.20 during trading hours on Friday, reaching $55.77. 2,013,000 shares of the company’s stock were exchanged, compared to its average volume of 4,500,405. Walgreens Boots Alliance Inc has a 1 year low of $49.03 and a 1 year high of $86.31. The stock has a market cap of $49.53 billion, a PE ratio of 9.26, a PEG ratio of 1.37 and a beta of 0.88. The company has a current ratio of 0.76, a quick ratio of 0.37 and a debt-to-equity ratio of 0.49. The stock’s fifty day moving average price is $52.37 and its two-hundred day moving average price is $54.62.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.42 by $0.05. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The business had revenue of $34.59 billion for the quarter, compared to analyst estimates of $34.52 billion. During the same quarter in the previous year, the firm earned $1.53 earnings per share. The company’s revenue was up .7% on a year-over-year basis. On average, equities analysts expect that Walgreens Boots Alliance Inc will post 5.98 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Stockholders of record on Tuesday, August 20th were paid a dividend of $0.458 per share. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. The ex-dividend date was Monday, August 19th. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.29%. Walgreens Boots Alliance’s payout ratio is presently 30.40%.

In other news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the business’s stock in a transaction dated Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the sale, the chief accounting officer now owns 357,851 shares in the company, valued at $18,064,318.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 15.73% of the stock is currently owned by insiders.

Several analysts recently weighed in on WBA shares. ValuEngine upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Friday, June 28th. Deutsche Bank started coverage on Walgreens Boots Alliance in a report on Thursday, September 12th. They issued a “sell” rating for the company. Morgan Stanley decreased their price objective on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating for the company in a report on Friday, August 23rd. Bank of America decreased their price objective on Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating for the company in a report on Monday, June 3rd. Finally, BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a report on Wednesday, September 11th. Seven equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $63.65.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: The Structure of a Futures Contract

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit